首页|基于网络药理学探讨益肾强骨合剂治疗肾阳虚型骨质疏松症的作用机制

基于网络药理学探讨益肾强骨合剂治疗肾阳虚型骨质疏松症的作用机制

Exploring the Mechanism of Yishen Qianggu Mixture in the Treatment of Osteoporosis of Kidney-Yang Deficiency Based on Network Pharmacology

扫码查看
目的:基于网络药理学探讨益肾强骨合剂治疗肾阳虚型骨质疏松症(OP)的作用机制.方法:利用DrugBank等数据库,检索OP相关靶点,通过中药系统药理学与分析平台(TCMSP)等数据库,挖掘益肾强骨合剂药物活性成分及作用靶点.获取药物-疾病交集靶点后,构建蛋白质互作(PPI)网络,对交集靶点进行京都基因和基因组百科全书(KEGG)、基因本体(GO)富集分析,并将富集结果进行可视化处理.根据PPI网络的Degree值,筛选出关键成分和靶点,进行分子对接和分子动力学模拟.结果:益肾强骨合剂的活性化合物包括槲皮素、豆固醇、叶黄素、山奈酚等,药物与OP交集靶点149个.通过PPI分析,得到益肾强骨合剂治疗OP的核心靶点,包括苏氨酸激酶1(AKT1)、白细胞介素-1β(IL-1β)、肿瘤坏死因子(TNF)、肿瘤蛋白53(TP53)、甘油醛-3-磷酸脱氢酶(GAPDH)、基质金属蛋白酶9(MMP9)及雌激素受体1(ESR1)等.KEGG信号通路富集主要包括缺氧诱导因子1(HIF-1)、丝裂原活化蛋白激酶(MAPK)信号通路等.GO富集分析中的生物过程主要包括RNA聚合酶Ⅱ的正向调节、细胞增殖的正向调节等.通过分子对接及分子动力学模拟发现,MMP9-槲皮素复合物最稳定,其次是ESR1-豆固醇、AKT1-叶黄素及AKT1-山奈酚.结论:益肾强骨合剂中有效成分槲皮素、豆固醇、叶黄素、山奈酚等作用于AKT1、IL-1β、TNF、TP53等关键靶点,发挥治疗肾阳虚型OP的作用.
Objective:To investigate the therapeutic mechanism of Yishen Qianggu Mixture for kidney-yang deficiency type osteoporosis(OP)based on network pharmacology.Methods:The OP-related targets were retrieved from DrugBank and other databases.The active ingredients and targets of Yishen Qianggu Mixture were excavated through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and other databases.After obtaining the intersection targets between drugs and diseases,the protein-protein interaction(PPI)network was constructed,and Kyoto Encyclopedia of Genes and Genomes(KEGG)and Gene Ontology(GO)enrichment analyses were performed on the intersection targets.The enrichment results were visualized.Based on the Degree value of the PPI network,key ingredients and targets were screened for molecular docking and molecular dynamics simulations.Results:The active compounds of Yishen Qianggu Mixture include quercetin,stigmasterol,lutein,kaempferol,etc.,and there are 149 intersection targets between drugs and OP.Through PPI analysis,the core targets of Yishen Qianggu Mixture for OP treatment were obtained,including threonine kinase 1(AKT1),interleukin-1β(IL-1β),tumor necrosis factor(TNF),tumor protein P53(TP53),glyceraldehyde 3-phosphate dehydrogenase(GAPDH),matrix metalloproteinase 9(MMP9),and estrogen receptor 1(ESR1).The enrichment of KEGG signaling pathways mainly includes hypoxia-inducible factor-1(HIF-1)and mitogen-activated protein kinase(MAPK)signaling pathways.The biological processes in GO enrichment analysis mainly include positive regulation of RNA polymerase Ⅱ and positive regulation of cell proliferation.Through molecular docking and molecular dynamics simulations,the MMP9-quercetin complex is the most stable,followed by ESR1-stigmasterol,AKT1-lutein,and AKTl-kaempferol complexes.Conclusion:The active ingredients of Yishen Qianggu Mixture,such as quercetin,stigmasterol,lutein,and kaempferol,act on key targets such as AKT1,IL-1β,TNF,and TP53 to play a therapeutic role in kidney-yang deficiency type OP.

Yishen Qianggu Mixtureosteoporosis(OP)network pharmacologymolecular docking

赵俊、罗斯佳、曾宇、黄觅

展开 >

湖北中医药大学 针灸骨伤学院,湖北 武汉 430065

武汉市中西医结合医院 脊柱外科,湖北 武汉 430030

益肾强骨合剂 骨质疏松症 网络药理学 分子对接

湖北省自然科学基金项目

2023AFD141

2024

巴楚医学
三峡大学

巴楚医学

ISSN:2096-6113
年,卷(期):2024.7(3)